SENS PubMed Publication Search
Somatic mutant clones colonize the human esophagus with age.
Science. 2018 Nov 23;362(6417):911-917. doi: 10.1126/science.aau3879
Martincorena I, Fowler JC, Wabik A, Lawson ARJ, Abascal F, Hall MWJ, Cagan A, Murai K, Mahbubani K, Stratton MR, Fitzgerald RC, Handford PA, Campbell PJ, Saeb-Parsy K, Jones PH
Abstract:
The extent to which cells in normal tissues accumulate mutations throughout life is poorly understood. Some mutant cells expand into clones that can be detected by genome sequencing. We mapped mutant clones in normal esophageal epithelium from nine donors (age range, 20 to 75 years). Somatic mutations accumulated with age and were caused mainly by intrinsic mutational processes. We found strong positive selection of clones carrying mutations in 14 cancer genes, with tens to hundreds of clones per square centimeter. In middle-aged and elderly donors, clones with cancer-associated mutations covered much of the epithelium, with NOTCH1 and TP53 mutations affecting 12 to 80% and 2 to 37% of cells, respectively. Unexpectedly, the prevalence of NOTCH1 mutations in normal esophagus was several times higher than in esophageal cancers. These findings have implications for our understanding of cancer and aging.
Comment in
* Colony takeover. [Nat Rev Cancer. 2018]
* The paradox of mutations and cancer. [Science. 2018]
* Accumulating mutations. [Nat Med. 2019]
* Mutations differ in normal and cancer cells of the oesophagus. [Nature. 2019]
* Mutation and clonal selection in the ageing oesophagus. [Nat Rev Gastroenterol Hepatol. 2019]
Comment in
* Colony takeover. [Nat Rev Cancer. 2018]
* The paradox of mutations and cancer. [Science. 2018]
* Accumulating mutations. [Nat Med. 2019]
* Mutations differ in normal and cancer cells of the oesophagus. [Nature. 2019]
* Mutation and clonal selection in the ageing oesophagus. [Nat Rev Gastroenterol Hepatol. 2019]
PMID: 10337457
Free Full-Text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298579/
Tags: cancer, DNA damage, esophagus, humans, NOTCH1, somatic mutations, TP53